V

Viking Therapeutics
D

VKTX

26.985
USD
-0.72
(-2.58%)
مغلق
حجم التداول
53,853
الربح لكل سهم
-2
العائد الربحي
-
P/E
-23
حجم السوق
3,030,673,072
أصول ذات صلة
A
ABUS
0.01500
(0.47%)
3.21500 USD
ALNY
ALNY
0.47
(0.16%)
289.82 USD
A
ARWR
-0.250
(-1.62%)
15.140 USD
C
CRBP
-0.15000
(-1.99%)
7.40000 USD
MRNA
MRNA
-0.820
(-3.03%)
26.280 USD
R
RGLS
-0.03000
(-0.38%)
7.89000 USD
V
VKTX
-0.715
(-2.58%)
26.985 USD
المزيد
الأخبار المقالات

العنوان: Viking Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.